Justine Koenigsberg | SVP-IR |
Roger Tung | CEO |
Marc Becker | CFO |
Jim Cassella | Chief Development Officer |
Jason Butler | JMP Securities |
Maury Raycroft | Jefferies |
Elaine Kim | Berenberg |
Alex Lim | Mizuho |
Good morning, and welcome to Concert Pharmaceuticals Third Quarter 2021 Investor Update.
Joining me this morning with prepared remarks are Roger Tung, our CEO; and Marc Becker, our CFO.
Our prepared comments today will be brief so we can jump right into the Q&A portion of the call.
We will then be joined by Nancy Stuart, our Chief Operating Officer; and Jim Cassella, our Chief Development Officer.
As a reminder, today's discussion will include forward-looking statements about our future expectations, plans and prospects.